CLINICAL_TRIALS
trial_result
· 2017-06-27
Clinical Trial Update: Ologen (OculusGen)-Glaucoma Case Control Trial in India [Phase 3]
Summary
Phase 3 glaucoma case-control trial of Ologen (OculusGen) completed in India, with Pro Top & Mediking Company Limited as sponsor.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pro Top & Mediking Company Limited | Conditions: Glaucoma | Phase 3 | Status: COMPLETED